These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2351859)

  • 41. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
    Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y
    Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
    Nakamura R; Saikawa Y; Kubota T; Nakamura T; Akatsu Y; Takahashi T; Yoshida M; Otani Y; Kumai K; Kitajima M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1323-6. PubMed ID: 16184933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):431-8. PubMed ID: 9063480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
    Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant ascites: a 2-year review from a teaching hospital.
    Parsons SL; Lang MW; Steele RJ
    Eur J Surg Oncol; 1996 Jun; 22(3):237-9. PubMed ID: 8654603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous bacterial peritonitis in malignant ascites.
    Gupta R; Misra SP; Dwivedi M; Misra V
    Indian J Gastroenterol; 1990 Jul; 9(3):239. PubMed ID: 2373538
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasmacytic ascites responsive to multiagent chemotherapy.
    Jackson SR; Hawkins TE; Green GJ; Carter JM; Romeril KR
    Am J Hematol; 1992 Dec; 41(4):298. PubMed ID: 1288296
    [No Abstract]   [Full Text] [Related]  

  • 49. [Carcinoma cell in ascites of peritonitis carcinomatosa].
    FUKUTOME T
    Gan; 1954 Sep; 45(2-3):187-8. PubMed ID: 13220815
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.
    Ishitani K; Isoai A; Ito T; Sugiyama H; Arakawa A; Yamada Y; Onodera H; Kobayashi R; Torii N; Soneda N; Matsuno Y; Utsugisawa T; Kato M; Hanafusa N
    Int J Clin Oncol; 2021 Jun; 26(6):1130-1138. PubMed ID: 33761026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of chemotherapy for comorbid cancer in patients with simultaneous double cancers: a multicenter study.
    Sohda M; Yokobori T; Kimura A; Kosaka T; Yoshida K; Hakamada K; Natsugoe S; Taketomi A; Saeki H; Shirabe K; Kuwano H
    Surg Today; 2023 Jan; 53(1):98-108. PubMed ID: 35913634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of Organoids from Malignant Ascites for Cancer Research in Oman.
    Khan F; Yaqoob N; AlYahyaee AH; AlZadjali SA; Burney IA
    Sultan Qaboos Univ Med J; 2024 Aug; 24(3):303-305. PubMed ID: 39234331
    [No Abstract]   [Full Text] [Related]  

  • 53. PATIENT with ascites.
    Cancer Bull; 1953; 5(1):7. PubMed ID: 13032936
    [No Abstract]   [Full Text] [Related]  

  • 54. Black ascites.
    Sato Y; Hayashi N; Takahashi S
    Nagoya J Med Sci; 2022 Aug; 84(3):686-688. PubMed ID: 36237875
    [No Abstract]   [Full Text] [Related]  

  • 55. The reversibility of cancer, 10 years on.
    Van der Merwe CF
    S Afr Med J; 1993 Jan; 83(1):69. PubMed ID: 8424221
    [No Abstract]   [Full Text] [Related]  

  • 56. [Multi-drug chemotherapy for patients with peritonitis carcinomatosa associated with ascites].
    Hirono M; Yoshihara T; Hayashi Y; Suzuki M; Majima H
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):672-8. PubMed ID: 2351859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
    Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical efficacy of two-route chemotherapy with CDDP and STS in patients with peritonitis carcinomatosa].
    Kuwahara A; Saito T; Nakashima K; Shigemitsu Y; Hirao E; Kobayashi M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2752-5. PubMed ID: 2782887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new chemosensitivity assay for ascites tumor cells using a thermoreversible gelation polymer as a culture medium and the observed clinical responses.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Eur Surg Res; 2007; 39(1):41-50. PubMed ID: 17213726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.